GDRX logo

GoodRx Holdings, Inc. Stock Price

NasdaqGS:GDRX Community·US$1.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 21 Fair Values set on narratives written by author

GDRX Share Price Performance

US$4.53
-2.52 (-35.74%)
35.3% undervalued intrinsic discount
US$7.00
Fair Value
US$4.53
-2.52 (-35.74%)
35.3% undervalued intrinsic discount
US$7.00
Fair Value
Price US$4.53
AnalystHighTarget US$7.00
AnalystConsensusTarget US$5.37
AnalystLowTarget US$3.40

GDRX Community Narratives

AnalystHighTarget·Updated
Fair Value US$7 35.3% undervalued intrinsic discount

Digital Transformation And Aging Trends Will Expand Affordable Prescription Access

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value US$5.37 15.6% undervalued intrinsic discount

Digital Health And Telemedicine Expansion Will Deepen Market Opportunity

0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
AnalystLowTarget·Updated
Fair Value US$3.4 33.2% overvalued intrinsic discount

Government Pricing Reforms And Tech Rivalries Will Reduce Future Prospects

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent GDRX News & Updates

Should You Think About Buying GoodRx Holdings, Inc. (NASDAQ:GDRX) Now?

Oct 02
Should You Think About Buying GoodRx Holdings, Inc. (NASDAQ:GDRX) Now?

GoodRx Holdings' (NASDAQ:GDRX) Performance Is Even Better Than Its Earnings Suggest

Aug 15
GoodRx Holdings' (NASDAQ:GDRX) Performance Is Even Better Than Its Earnings Suggest

Little Excitement Around GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Revenues As Shares Take 28% Pounding

Aug 08
Little Excitement Around GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Revenues As Shares Take 28% Pounding

GoodRx Holdings, Inc. Key Details

US$799.9m

Revenue

US$50.6m

Cost of Revenue

US$749.3m

Gross Profit

US$714.7m

Other Expenses

US$34.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.10
Gross Margin
93.68%
Net Profit Margin
4.33%
Debt/Equity Ratio
76.2%

GoodRx Holdings, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet and fair value.

2 Risks
3 Rewards

About GDRX

Founded
2011
Employees
738
CEO
Wendy Barnes
WebsiteView website
www.goodrx.com

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solution for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 1.2%
  • 3 Months: 8.5%
  • 1 Year: 17.7%
  • Year to Date: 14.8%
The market is up 1.2% over the last week, with the Information Technology sector leading the way, up 2.4%. As for the past 12 months, the market is up 18%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›